Propafenone Hydrochloride Capsule, Extended Release
Product Images NDC 0832-0741

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Propafenone Hydrochloride (NDC 0832-0741). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Upsher-smith Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Propafenone 01)

FDA Label Image

Figure 1 (Propafenone 02)

Figure 1 (Propafenone 02)
This appears to be a graph or table showing the proportion of patients without an event over time for a medication called Propafenone ER compared to a placebo. The graph includes doses of 225 mg and 425 mg taken twice daily. The text also includes statistics with p-values of less than 0.001.*
FDA Label Image

Principal Display Panel (225 mg Capsule Bottle Label)

Principal Display Panel (225 mg Capsule Bottle Label)
Each capsule contains 225mg Propafenone Hydrochiorde, USP. It is advised to refer to the package insert for dosage information. The drug should be stored at temperatures between 20°C and 25°C (68°F to 77°F) with excursions allowed to 15°C to 30°C (59°F to 86°F). It should be dispensed in a tightly sealed, light-resistant container as per the USP standards. The drug is manufactured and sold by Upsher-Smith Laboratories and a prescription is required to purchase it.*
FDA Label Image

Principal Display Panel (325 mg Capsule Bottle Label)

Principal Display Panel (325 mg Capsule Bottle Label)
Each capsule of this medication contains 325 mg of Propafenone Hydrochloride, USP. The usual dosage instructions are available in the package insert. The medication should be stored at room temperature between 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F) [See USP Controlled (SUCNIGH B GRTLRY Room Temperature)]. The capsules should be dispensed in a tightly sealed, light-resistant container, as defined in the USP, with a child-resistant closure. The medication is only available with a prescription and should be kept out of reach of children. The medication is manufactured by Upsher-Smith Laboratories, LLC and each package contains 60 capsules.*
FDA Label Image

Principal Display Panel (425 mg Capsule Bottle Label)

Principal Display Panel (425 mg Capsule Bottle Label)
Each capsule of this medication contains 425mg of Propafenone Hydrochloride, USP. The usual dosage is indicated in the package insert. It should be stored at the room temperature of 20° to 25°C (68" to 77°F), with excursions permitted between 15° to 30°C (59° to 86°F) as controlled by USP. It must be kept in a light-resistant container, and is sealed for protection. This medication is manufactured by Upsher-Smith Laboratories, LLC and comes in 60 capsules that can only be obtained by prescription.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.